Philips Partners with LeQuest to Provide Online Interactive Training in Ultrasound

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and LeQuest, a leading provider of online interactive simulation-based training for the use of medical devices [1], today announced a partnership to provide online interactive training for the Philips Ultrasound Affiniti system. As a result, medical staff can train individually at their own convenience without the need for equipment, avoiding the resulting loss of operational time on the system, as well as supporting faster onboarding and increasing confidence through practice with realistic simulation scenarios. Healthcare providers benefit from improved workflow, operational efficiencies and better-trained staff.

The Affiniti system offers healthcare professionals a powerful combination of performance and workflow for quick and efficient diagnosis with low operating cost, providing exceptional image quality across applications such as radiology, obstetrics & gynecology, and cardiology. By providing a flexible training solution to healthcare providers, the partnership supports them to achieve key parts of the quadruple aim: an improved experience for staff and patients, better health outcomes and a lower cost of care.

"Partnering with LeQuest enables us to further expand our offering of solutions that aid in optimizing the healthcare ecosystem," said Bich Le, Senior Vice President and General Manager Ultrasound at Philips. "As the role of ultrasound continues to expand, new capabilities, such as remote clinical collaboration and virtual training, have been particularly valuable during the COVID-19 pandemic, enabling providers to reduce in-person contact and reduce infection risk."

"At LeQuest our goal is to improve the quality of care by unlocking the potential of both medical technology as well as the competence of medical staff to use devices to the limit of their possibilities," said Hicham Shatou, founder and CEO of LeQuest. "Our partnership with Philips is an important step on our path to achieving that ambition, extending the global reach of our capabilities and providing Philips ultrasound users with a hands-on experience of its Affiniti system in a virtual environment."

With the LeQuest training modules, users can master the system in an effective way, gain confidence by practicing with realistic simulation scenarios and learn and practice anytime, anywhere. Training modules are available for all models of the Affiniti system (Affiniti 30, 50, 70) with specific versions for each clinical segment (general imaging, obstetrics/gynecology, and cardiology). The LeQuest training modules for the Philips Ultrasound Affiniti system are currently available in LATAM, France, Benelux and Nordics and more countries will follow soon. For more information visit www.lequest.com/en/philips-affiniti.

The partnership with LeQuest adds to Philips' strong portfolio of Clinical Education Services in ultrasound. Helping to combat the COVID-19 pandemic, the company is also providing detailed, practical guidance to support clinicians using its ultrasound systems and software for patients affected by COVID-19. Through its Reacts collaborative platform, Philips is expanding its remote clinical collaboration and virtual training offerings across its portfolio.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries.

About LeQuest

LeQuest, founded in 2011 is a leading technology company focused on improving the quality of care by unlocking the potential of both medical technology as well as the competence of medical staff to use devices to the limit of their possibilities. We are developing online interactive simulation-based e- training for the use of medical devices. The LeQuest e-trainings accelerate the implementation of new medical equipment, close the consumption gap, and make users quickly gain confidence, knowledge and competence within a safe environment including certifying and re-certifying of the medical staff. LeQuest is a fast growing company. LeQuest was recently recognized as one of the 250 fastest-growing companies in the Netherlands for 2020.

1. Since 2017, Philips has owned a minority interest in LeQuest through its Philips Health Technology Venture Fund. For more information, please visit www.ventures.philips.com.

Most Popular Now

Stanford Medicine Study Suggests Physici…

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For...

Adults don't Trust Health Care to U…

A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care...

AI Unlocks Genetic Clues to Personalize …

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes - insights that could help doctors tailor...

The 10 Year Health Plan: What do We Need…

Opinion Article by Piyush Mahapatra, Consultant Orthopaedic Surgeon and Chief Innovation Officer at Open Medical. There is a new ten-year plan for the NHS. It will "focus efforts on preventing, as...

People's Trust in AI Systems to Mak…

Psychologists warn that AI's perceived lack of human experience and genuine understanding may limit its acceptance to make higher-stakes moral decisions. Artificial moral advisors (AMAs) are systems based on artificial...

Deep Learning to Increase Accessibility…

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...

To be Happier, Take a Vacation... from Y…

Today, nearly every American - 91% - owns a cellphone that can access the internet, according to the Pew Research Center. In 2011, only about one-third did. Another study finds...

Researchers Find Telemedicine may Help R…

Low-value care - medical tests and procedures that provide little to no benefit to patients - contributes to excess medical spending and both direct and cascading harms to patients. A...